TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07447076: Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Sponsor: Sabine Mueller, MD, PhD · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 29 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$554,400

Rescue Site Savings

+$369,600

Unlock Full NCT07447076 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07447076 Rescue Dossier →